Y
Yan Chen
Researcher at Xiamen University
Publications - 8
Citations - 904
Yan Chen is an academic researcher from Xiamen University. The author has contributed to research in topics: Nerve growth factor IB & Autophagy. The author has an hindex of 7, co-authored 8 publications receiving 781 citations.
Papers
More filters
Journal ArticleDOI
GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy.
Shu-Yong Lin,Terytty Yang Li,Qing Liu,Cixiong Zhang,Xiaotong Li,Yan Chen,Shi-Meng Zhang,Guili Lian,Qi Liu,Ka Ruan,Zhen Wang,Chen-Song Zhang,Kun-Yi Chien,Jia-Wei Wu,Qinxi Li,Jiahuai Han,Sheng-Cai Lin +16 more
TL;DR: These findings uncover an activating pathway that integrates protein phosphorylation and acetylation to connect growth factor deprivation to autophagy when deprived of serum but not glucose.
Journal ArticleDOI
Orphan nuclear receptor TR3 acts in autophagic cell death via mitochondrial signaling pathway
Wei-jia Wang,Yuan Wang,Hang-zi Chen,Yong-zhen Xing,Feng-wei Li,Qian Zhang,Bo Zhou,Hong-Kui Zhang,Jie Zhang,Xue-li Bian,Li Li,Yuan Liu,Bi-xing Zhao,Yan Chen,Rong Wu,An-zhong Li,Lu-ming Yao,Chen Ping,Yi Zhang,Xu-yang Tian,Friedrich Beermann,Mian Wu,Jiahuai Han,Pei-Qiang Huang,Tianwei Lin,Qiao Wu +25 more
TL;DR: It is discovered that melanoma, which is generally resistant to drug-induced apoptosis, can undergo autophagic cell death with the participation of orphan nuclear receptor TR3, and implicates a new approach to melanoma therapy through activation of a mitochondrial signaling pathway that integrates a nuclear receptor with autophagy for cell death.
Journal ArticleDOI
The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK
Yan-yan Zhan,Yan Chen,Qian Zhang,Jia-Jia Zhuang,Min Tian,Hang-zi Chen,Lianru Zhang,Hong-Kui Zhang,Jian-ping He,Wei-jia Wang,Rong Wu,Yuan Wang,Chunfang Shi,Kai Yang,An-zhong Li,Yong-zhen Xin,Terytty Yang Li,James Y. Yang,Zhonghui Zheng,Chun-dong Yu,Sheng-Cai Lin,Chawnshang Chang,Pei-Qiang Huang,Tianwei Lin,Qiao Wu +24 more
TL;DR: It is demonstrated that the orphan nuclear receptor Nur77 binds and sequesters LKB1 in the nucleus, thereby attenuating AMPK activation and implicates Nur77 as a new and amenable target for the design and development of therapeutics to treat metabolic diseases.
Journal ArticleDOI
Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation
Li Li,Yuan Liu,Hang-zi Chen,Feng-wei Li,Jianfeng Wu,Hong-Kui Zhang,Jian-ping He,Yong-zhen Xing,Yan Chen,Wei-jia Wang,Xu-yang Tian,An-zhong Li,Qian Zhang,Pei-Qiang Huang,Jiahuai Han,Tianwei Lin,Qiao Wu +16 more
TL;DR: It is shown that orphan nuclear receptor Nur77 (also known as TR3) can enhance resistance to lipopolysaccharide-induced sepsis in mice by inhibiting NF-κB activity and suppressing aberrant cytokine production.
Journal ArticleDOI
A Unique Pharmacophore for Activation of the Nuclear Orphan Receptor Nur77 In vivo and In vitro
Jingjing Liu,Huini Zeng,Lianru Zhang,Yan-yan Zhan,Yan Chen,Yuan Wang,Juan Wang,Shao-hua Xiang,Wen-Jun Liu,Wei-jia Wang,Hang-zi Chen,Yuemao Shen,Wenjin Su,Pei-Qiang Huang,Hong-Kui Zhang,Qiao Wu +15 more
TL;DR: A pathway for rational design of Csn-B-derived Nur77 agonists as a new class of potent and effective antitumor agents is described.